instruction:
Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
question:
Evolocumab met the main goal of a late-stage trial titled RUTHERFORD-2 by lowering “bad” LDL cholesterol levels when tested against a placebo on 329 patients. Amgen, the world’s biggest biotechnology company, is testing evolocumab widely on a variety of subpopulations. The RUTHERFORD-2 study included patients with familial hypercholesterolemia, an inherited condition that causes high levels of “bad” LDL cholesterol starting at birth. Specifically, patients in the study had heterozygous familial hypercholesterolemia, which is one of the most common genetic disorders affecting about one out of every 300 to 500 people worldwide, according to Amgen. The company on Tuesday reported positive results from a fourth late-stage study of evolocumab, for which it plans to begin seeking approvals this year. The drug is intended for people who cannot tolerate widely used statins, or who are unable to get their LDL levels low enough despite using high potency statins, such as AstraZeneca’s Crestor. Amgen’s shares closed at $120.89 on the Nasdaq on Thursday.
answer:
Amgen's cholesterol fighter succeeds in fifth late-stage study.


question:
"In a press conference on May 5 in which Gov. Greg Abbott updated his reopening plan to add businesses such as hair salons and gyms, he recommended that at-risk populations ""remain at home if at all possible"" and avoid in-person gatherings, such as a church service, funeral or wedding. ""We strongly encourage at-risk populations to try to watch or participate remotely, remembering this very important point, and that is almost 75 percent of the deaths from COVID-19 in the state of Texas are a result of people contracting COVID-19 who are age 65 and older,"" Abbott said. Texas was among the first states to start reopening businesses and lifting restrictions put in place to curb the spread of the coronavirus, allowing retail stores and restaurants to open May 1 at 25 percent capacity. Abbott announced the latest set of reopenings Monday, expanding restaurant capacity to 50 percent and granting bars the ability to open at 25 percent capacity within the next couple weeks. This comes as the state continues to see its number of infections and deaths rise and clusters form mostly in rural parts of the state where meatpacking plants are located. Hospitalizations, however, have decreased since mid-April. With that in mind, we had to ask: Is Abbott right that almost 75% of coronavirus deaths in Texas are people older than 65? Looking at the numbers Abbott’s spokesman John Wittman said Abbott’s claim is based on figures from the Texas Department of Health Services, which publishes daily numbers on the state’s COVID-19 testing and cases. The data includes a breakdown of coronavirus deaths by age, race and gender, but only for those cases where the deaths have been investigated by the local and regional health departments. As of Wednesday, the majority, or 489, were still under investigation. ""The demographic data on cases and fatalities come from the case investigation forms submitted by local health departments and our regional offices,"" said DSHS spokesman Chris Van Deusen. The purpose of the investigation is to confirm that the person had COVID-19 but also to collect other details about them and the circumstances around their death, Van Deusen said. Wittman said the data showed that 75% of investigated deaths were people 65 and older when Abbott made this statement. ""It alternates almost daily, but it’s generally around that range,"" Wittman said. As of May 6, the day after the press conference, the death toll in Texas was 948. Fewer than half, or 433, had been investigated. Of those, about 71 percent were Texans 65 and older. It was still about 71 percent, or 345 out of 489 investigated cases, as of Wednesday. The age groups broke down like so: Ages 10 to 19 years old: 2 deaths, or 0.4% Ages 20-29: 10 deaths, or 2.04 % Ages 30-39: 9 deaths, or 1.8% Ages 40-49: 21 deaths, or 4.29% Ages 50-59: 54 deaths, or 11.04% Ages 60-64: 45 deaths, or 9.2% Ages 65-69: 59 deaths, or 12.06% Ages 70-74: 45 deaths, or 9.2% Ages 75-79: 45 deaths, or 9.2% Ages 80+: 196 deaths, or 40.08% Across the United States, about 79% of coronavirus deaths have been people 65 years and older, according to the National Center for Health Statistics data submitted between the beginning of February to the beginning of May. Like Texas’ statistics, the national numbers are also incomplete. The number of deaths represent only those entered between those dates and only include people with confirmed or presumed COVID-19. ""While 80% of deaths are electronically processed and coded by NCHS within minutes, most deaths from COVID-19 must be coded by a person, which takes an average of 7 days,"" the NCHS states on its website. The data is also always somewhat behind because of the lag time between when a death occurred and when a death certificate is completed, submitted to NCHS and processed for reporting purposes. The delay can last anywhere from one week to eight or more. Our ruling Abbott said almost ""75 percent of the deaths from COVID-19 in the state of Texas are a result of people contracting COVID-19 who are age 65 and older."" Of confirmed coronavirus deaths, close to 75% were people within the age group Abbott provided, but he failed to include the caveat that this statistic leaves out more than half of the total deaths that have not yet been investigated."
answer:
“Almost 75 percent of the deaths from COVID-19 in the state of Texas are a result of people contracting COVID-19 who are age 65 and older.”


question:
There are four slashes among the women’s siblings, others among her immediate family, and most family members’ symbols are partially colored in. Each partially filled circle represents a cancer diagnosis. Each slash indicates a death. Although white women get breast cancer more frequently, it’s usually diagnosed later and is more severe in African American women. Breast cancer death rates among black women were about 40 percent higher than among white women between 1999 and 2013, according to the Centers for Disease Control. Ricks-Santi, director of the Hampton University Cancer Research Center, and another Hampton colleague, John McDonald, recently received a $446,000 grant from the National Institutes of Health to study the genetics behind breast cancer diagnoses in African American women. In particular, they’re trying to refine genetic tests that don’t seem to be as effective for black women as white. “I wanted to make sure that there was equity in the way that genetics and genomics was being applied across populations,” Ricks-Santi said. She has a longstanding interest in cancer research, dating back to when she was a kid. Her family has a history of cancer; her father has prostate cancer. That led her to pursue an undergraduate degree at Hampton University and a Ph.D. from Georgetown University. She worked as a post-doctoral fellow in a joint cancer studies program between Georgetown and Howard University. There, she saw a trend among genetic tests for breast cancer, particularly the most common ones, BRCA 1 and 2. They are sometimes an indicator for some of the hardest to treat forms, and they’re also correlated with other kinds of cancer in men and women. At Georgetown’s cancer center, which Ricks-Santi said served mostly white and affluent patients, BRCA tests often helped doctors decide if women were candidates for preventative treatment or if they needed additional testing. At Howard’s cancer center, which served more black patients, BRCA tests often came back inconclusive. This, Ricks-Santi said, makes it hard for oncologists to come up with specific, informed approaches for patients of color. “You can’t do that if you’re not identifying the right risk factor, the right gene,” said Melissa Gomes, a mental health nurse practitioner and a co-investigator on the study. “You can’t make that personalized approach if it wasn’t based on a population that included you.” The study that Ricks-Santi and McDonald are leading uses family history and genetic data from 300 breast cancer patients at Howard, along with relatives without cancer diagnoses and other types of cancer. Ricks-Santi will conduct statistical research to find candidate genes that could provide a better test. McDonald, an assistant professor of physics, will then conduct the laboratory phase of the study, injecting those genes into cancer cells in Petri dishes to determine exactly what kind of effect those have. They’re also working with Hampton University students on the project, who will be paid with grant money. “It’s nice to create that pipeline of researchers that look like the population we want to study,” Gomes said. This round of funding lasts for three years. But they’re already looking toward the next phase. That’s where Gomes’ experience comes in, whose background is clinical psychiatry. She sees patients four days a week. In a second study, once they’ve isolated some possible genes, they want to control for those genes and then investigate social circumstances that might contribute to breast and other kinds of cancer. Gomes hopes to use her background in psychiatry and patient care to help build connections in Hampton Roads in addition to helping with the social research. “Nurses are considered one of the most trusted health professionals,” Gomes said. “I think that the community trusts us and they value their opinion.” Ricks-Santi is hopeful about this holistic approach, citing her father’s own experience. Because of the small size of his tumor, they took a more wait-and-see approach to treatment. He moved to Puerto Rico for six months to relax. It seemed to work. His prostate-specific antigen levels, an indicator of that kind of cancer, dropped significantly and have stayed stable. “It’s scary and exciting,” Ricks-Santi said. “There’s so many possibilities.” ___ Information from: Daily Press, http://www.dailypress.com/
answer:

University studies cancer risk and testing for black women.